May 27, 2026
John Boozman- Amount
- $1,001 to $15,000
- Filed
- Jun 16, 2026
Congress ticker disclosure profile
As of August 1 at 11:20 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference SCHP. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
1
Feed lifetime
11
Member filers
4
Disclosed ranges
$414K
Most active member desks
7 buys vs 4 sells
Latest trade May 27, 2026
May 27, 2026
John BoozmanMay 13, 2026
John BoozmanSep 16, 2025
John BoozmanAug 1, 2025
John BoozmanSep 6, 2024
John BoozmanJun 26, 2024
John BoozmanFeb 20, 2024
John BoozmanDec 2, 2022
Carol Devine MillerNov 1, 2022
Carol Devine MillerMar 13, 2018
Jackie SpeierJan 30, 2015
Virginia Foxx| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| May 27, 2026 | John Boozman | Buy | $1,001 to $15,000 | Jun 16, 2026 | Open card |
| May 13, 2026 | John Boozman | Sell | $1,001 to $15,000 | Jun 16, 2026 | Open card |
| Sep 16, 2025 | John Boozman | Buy | $1,001 to $15,000 | May 11, 2026 | Open card |
| Aug 1, 2025 | John Boozman | Buy | $1,001 to $15,000 | Sep 12, 2025 | Open card |
| Sep 6, 2024 | John Boozman | Buy | $1,001 to $15,000 | Oct 18, 2024 | Open card |
| Jun 26, 2024 | John Boozman | Buy | $1,001 to $15,000 | Jul 11, 2024 | Open card |
| Feb 20, 2024 | John Boozman | Sell | $1,001 to $15,000 | May 8, 2024 | Open card |
| Dec 2, 2022 | Carol Devine Miller | Sell | $100,001 to $250,000 | Jan 4, 2023 | Open card |
| Nov 1, 2022 | Carol Devine Miller | Buy | $1,001 to $15,000 | Dec 13, 2022 | Open card |
| Mar 13, 2018 | Jackie Speier | Buy | $100,001 to $250,000 | Mar 13, 2018 | Open card |
| Jan 30, 2015 | Virginia Foxx | Sell | Receipt pending ingestion | Feb 9, 2015 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 10 of 11 filed rows include disclosed amount ranges (91%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.